Vicarious Surgical NYSE delisting; President and CTO take salary cuts

Vicarious Surgical Inc.

NYSE commenced delisting proceedings on March 3, 2026; stock now quoted on OTC under RBOT.
President Adam Sachs salary reduced to ~$270,810 annual; CTO Sammy Khalifa to ~$318,600, eff. March 9.
Target bonus and severance still calculated on prior higher salaries; executives waive Good Reason claims.
Salary cuts described as voluntary; no changes to post-employment obligations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.